Microbe-based pharmaceutical agents
ActoBio Therapeutics™ is pioneering a new class of safe, effective and easy-to-use treatments called ActoBiotics® for autoimmune and allergic disorders based on the well-characterized food-grade bacterium Lactococcus lactis.

Our first task for ActoBio was to create a new brand identity to communicate their scientific breakthroughs. We created various hard copy and digital communication assets including new website, corporate presentations, custom disease icons, full rebranding (concept, logo, brand promise, tagline).

We created a new PowerPoint template based on the new brand guidelines and updated and redesigned all slides to fit. We updated the copy to streamline the presentation, as well as recreating various charts and figures from the raw scientific data to ensure consistency between the slides. When necessary we assist with updating or creating new presentations or slides, coordinating internal reviews and distributing approved updated presentations, as well as providing a Chinese translation of the presentation.

“Kristoff and his team of joyful hard working ‘monkeys’ did a great job at rebranding our  company. During this process we benefited from Kristoff’s broad experience and network. “

Dr. Pieter Rottiers   – CEO  –  ActoBio Therapeutics

Infographic showing the impact of type 1 diabetes on patients

Custom-designed icons representing various diseases and modes of action

Presentation, including a custom-made figure of a leaky gut 

For more information
Next Project
Don’t leave your food safety to trial and error
Diversey Consulting